These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27915084)

  • 1. Predicting hospitalization and mortality in patients with heart failure: The BARDICHE-index.
    Uszko-Lencer NHMK; Frankenstein L; Spruit MA; Maeder MT; Gutmann M; Muzzarelli S; Osswald S; Pfisterer ME; Zugck C; Brunner-La Rocca HP;
    Int J Cardiol; 2017 Jan; 227():901-907. PubMed ID: 27915084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival after hospitalization for acute heart failure--differences in prognosis of acutely decompensated chronic and new-onset acute heart failure.
    Lassus JP; Siirilä-Waris K; Nieminen MS; Tolonen J; Tarvasmäki T; Peuhkurinen K; Melin J; Pulkki K; Harjola VP;
    Int J Cardiol; 2013 Sep; 168(1):458-62. PubMed ID: 23073273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise duration and peak systolic blood pressure are predictive of mortality in ambulatory patients with mild-moderate chronic heart failure.
    Williams SG; Jackson M; Ng LL; Barker D; Patwala A; Tan LB
    Cardiology; 2005; 104(4):221-6. PubMed ID: 16158008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Nutritional Index and the Risk of Mortality in Patients With Acute Heart Failure.
    Cheng YL; Sung SH; Cheng HM; Hsu PF; Guo CY; Yu WC; Chen CH
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure.
    Voors AA; Ouwerkerk W; Zannad F; van Veldhuisen DJ; Samani NJ; Ponikowski P; Ng LL; Metra M; Ter Maaten JM; Lang CC; Hillege HL; van der Harst P; Filippatos G; Dickstein K; Cleland JG; Anker SD; Zwinderman AH
    Eur J Heart Fail; 2017 May; 19(5):627-634. PubMed ID: 28247565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
    Hillege HL; Nitsch D; Pfeffer MA; Swedberg K; McMurray JJ; Yusuf S; Granger CB; Michelson EL; Ostergren J; Cornel JH; de Zeeuw D; Pocock S; van Veldhuisen DJ;
    Circulation; 2006 Feb; 113(5):671-8. PubMed ID: 16461840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure.
    Fu S; Xie L; Li D; Ye P; Luo L
    Clin Interv Aging; 2015; 10():359-65. PubMed ID: 25670892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
    Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P
    Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM
    JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Incremental Prognostic Utility of Increasingly Complex Testing in Chronic Heart Failure.
    Ahmad T; O'Brien EC; Schulte PJ; Stevens SR; Fiuzat M; Kitzman DW; Adams KF; Kraus WE; Piña IL; Donahue MP; Zannad F; Whellan DJ; O'Connor CM; Felker GM
    Circ Heart Fail; 2015 Jul; 8(4):709-16. PubMed ID: 26034004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure.
    Schou M; Gustafsson F; Corell P; Kistorp CN; Kjaer A; Hildebrandt PR
    Am Heart J; 2007 Jul; 154(1):123-9. PubMed ID: 17584564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of a multi-marker risk score for predicting cause-specific mortality at three years in older patients with heart failure and reduced ejection fraction.
    Bjurman C; Holmström A; Petzold M; Hammarsten O; Fu ML
    Cardiol J; 2015; 22(1):31-6. PubMed ID: 24526512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
    Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
    Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease.
    Poletti R; Vergaro G; Zyw L; Prontera C; Passino C; Emdin M
    Int J Cardiol; 2013 Aug; 167(3):711-5. PubMed ID: 22459392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictive value of cardiopulmonary exercise testing in various categories of patients with chronic heart value].
    Giverts IIu; Poltavskaia MG; Brand AV; Dikur ON; Andreev DA; Doletskiĭ AA; Sviridenko VP; Pesheva OV; Sedov VP; Chomakhidze PSh; Iakubovskaia EE; Syrkin AL
    Kardiologiia; 2013; 53(12):33-40. PubMed ID: 24800479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.